Omicron News and Research

RSS

Supreme Court weighs Biden’s workplace vaccine requirements

The Supreme Court on Friday took up one of the most contentious issues of the covid-19 pandemic, hearing a series of cases challenging the Biden administration's authority to require workers to get a covid vaccine or be tested for the virus regularly.

7 Jan 2022

NEJM article distills available data into a compendium about rapid diagnostic tests for COVID-19

A clinical practice article in the New England Journal of Medicine distills available data and clinical experience into a compendium about rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19.

7 Jan 2022

Scientists discover antibody that inhibits a broad range of sarbecoviruses

Scientists have discovered an antibody that may lead to more effective treatments against a wide range of sarbecoviruses, the family of viruses that includes the coronavirus SARS-CoV-2 and their variants.

7 Jan 2022

December 2021 nTIDE report: Job numbers for people with disabilities remain above pre-pandemic levels

Despite a small decline in December, the job numbers for people with disabilities remained above pre-pandemic levels, according to today's National Trends in Disability Employment – Monthly Update (nTIDE), issued by Kessler Foundation and the University of New Hampshire's Institute on Disability (UNH-IOD).

7 Jan 2022

Omicron variant found to be much less sensitive to neutralizing antibodies than Delta

The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries.

7 Jan 2022

Booster mRNA vaccination effective in reviving anti-SARS-CoV-2 antibody titers among the elderly

A new study found that a booster dose vaccination against COVID-19 was successful in taking binding. and neutralizing antibodies to levels higher than those observed after the initial double-dose regimen.

7 Jan 2022

SARS-CoV-2 Omicron variant leads to widespread escape from neutralizing antibody responses

A new study reported the neutralization of Omicron by a large panel of sera collected from convalescent early pandemic, Alpha, Beta, Gamma and Delta infected individuals, as well as among vaccinees receiving three doses of the Oxford/AstraZeneca (AZD1222) or the Pfizer BioNtech (BNT16b2) vaccines.

7 Jan 2022

Model suggests feasibility of shorter COVID-19 isolation period with minimal risk

Researchers set up a model that included parameters such as the infectiousness of the individual, and lateral flow testing, in order to assess the effectiveness of test-to-release policies as compared to those with fixed-duration isolation mandates

7 Jan 2022

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

Researchers from India have now successfully grown and isolated the Omicron variant from hamsters in vivo with further culturing in the Vero CCL-81 cells in vitro, in a step forward towards testing the effectiveness of existing SARS-CoV-2 vaccines and generation of new Omicron appropriate vaccines.

7 Jan 2022

Epidemic model for estimating relative transmissibility and immune escape of SARS-CoV-2 Omicron variant in South Africa

A new study developed a stochastic, multi-strain, compartmental epidemic model to estimate the relative transmissibility and immune escape capacity of the Omicron variant.

7 Jan 2022

Broad cross-neutralization antibodies found to be effective against SARS-CoV-2 Omicron variant

A new study aimed to explore whether there is a way to induce the production of potent neutralizing antibodies capable of neutralizing all SARS-CoV-2 variants - including Omicron.

7 Jan 2022

Additional SARS-CoV-2 vaccine doses elicit robust seroresponse among patients receiving maintenance dialysis

Researchers thus recently published a report wherein they examined the seroresponse to an additional dose of vaccine in patients on maintenance dialysis.

7 Jan 2022

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

London Medical Laboratory warns that its testing reveals nearly one in five people still have insufficient Covid antibodies.

7 Jan 2022

SARS-CoV-2 Omicron less pathogenic in hamsters

A new research paper posted as a preprint to the bioRxiv* server attempts to throw some light on this question by studying viral pathogenicity in golden hamsters, a valuable model for severe COVID-19 due to the development of reproducible weight loss and pneumonia after infection with the virus.

6 Jan 2022

Omicron News and Research

Supreme Court weighs Biden’s workplace vaccine requirements

NEJM article distills available data into a compendium about rapid diagnostic tests for COVID-19

Scientists discover antibody that inhibits a broad range of sarbecoviruses

December 2021 nTIDE report: Job numbers for people with disabilities remain above pre-pandemic levels

Omicron variant found to be much less sensitive to neutralizing antibodies than Delta

Booster mRNA vaccination effective in reviving anti-SARS-CoV-2 antibody titers among the elderly

SARS-CoV-2 Omicron variant leads to widespread escape from neutralizing antibody responses

Model suggests feasibility of shorter COVID-19 isolation period with minimal risk

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

Epidemic model for estimating relative transmissibility and immune escape of SARS-CoV-2 Omicron variant in South Africa

Broad cross-neutralization antibodies found to be effective against SARS-CoV-2 Omicron variant

Additional SARS-CoV-2 vaccine doses elicit robust seroresponse among patients receiving maintenance dialysis

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

SARS-CoV-2 Omicron less pathogenic in hamsters

SARS-CoV-2 Omicron belongs to new antigenic cluster compared to all other VOCs

Evaluating the response of lung cancer patients to COVID-19 mRNA vaccination

How effective are COVID-19 vaccines against the Omicron and Delta variants?

Scientists assess effectiveness of neutralizing antibodies against seven SARS-CoV-2 variants, including Omicron

Antibody binding response significantly reduced for Omicron compared to other SARS-CoV-2 variants

KHN’s ‘What the Health?’: Contagion confusion

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News